DURECT CORPORATION

HQ - Cupertino

Summary

DURECT Corporation is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 14 M

Avg. Deal Size£ 14 M

Market Context

Senior Management